In the exacting field of pharmaceutical manufacturing, the purity of chemical intermediates directly correlates with the quality and efficacy of the final drug product. NINGBO INNO PHARMCHEM CO.,LTD. is committed to upholding the highest standards by supplying 3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate (CAS: 179688-53-0), a critical intermediate for the synthesis of Gefitinib. This compound, with its molecular formula C11H10N2O4, is meticulously produced to ensure it meets the stringent requirements for pharmaceutical intermediate manufacturing.

The importance of sourcing Gefitinib production raw materials with verified purity cannot be overstated. Our 3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate is presented as an off-white to grey powder with an assured HPLC purity of ≥98.0%. This high purity is essential for avoiding unwanted by-products and ensuring a predictable and efficient synthesis of Gefitinib. NINGBO INNO PHARMCHEM CO.,LTD.’s dedication to quality control of chemical intermediates means that manufacturers can rely on our materials to contribute positively to their API production processes.

Beyond purity, understanding the comprehensive physical and chemical properties of these intermediates is vital. For 3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate, this includes characteristics like its melting point of 26°C and its refractive index. These details are crucial for developing robust manufacturing protocols. By providing these high-quality Gefitinib synthesis intermediates, NINGBO INNO PHARMCHEM CO.,LTD. supports companies in maintaining the integrity and safety of their pharmaceutical products, ensuring compliance with global regulatory standards.

Our role extends beyond mere supply; we act as a partner in the pharmaceutical manufacturing ecosystem. By consistently delivering high-purity Gefitinib production raw materials, NINGBO INNO PHARMCHEM CO.,LTD. contributes to the reliable and efficient production of life-changing medications. The meticulous quality control of chemical intermediates is a fundamental aspect of our operations, ensuring the success of our clients' complex synthetic endeavors.